They can damage your skin and increase your risk of skin cancer
Abstract Enteroendocrine L-cell derived peptide hormones, notably glucagon-like peptide-1 (GLP-1) and glucagon-like peptide-2 (GLP-2), have become important targets in the treatment of type 2 diabetes, obesity and intestinal diseases
It works by simultaneously activating three incretin and metabolic hormone receptors: the glucagon-like peptide-1 (GLP-1) receptor, the glucose-dependent insulinotropic polypeptide (GIP) receptor, and the glucagon receptor
Serious (but rare) risks include pancreatitis and gallbladder issues
No dairy, starch, sugar, wheat, gluten, yeast, corn, egg, fish, shellfish, salt or tree nuts